STRO — SUTRO BIOPHARMA INC
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 106 家机构在其最新 13F 申报中持有 STRO(SUTRO BIOPHARMA INC),合计申报市值 $552.84M,对应 16.71M 股。按股数计算较上季度增持 15.7%(+1.99M 股),申报市值环比上升 54.2%。持仓集中度较高:前五大持有人占申报市值的 35.5%,前十大的集中度为 57.2%。
与上一季度相比,46 家新建仓位、23 家加仓、17 家减仓、19 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
SUTRO BIOPHARMA INC(STRO)的主要机构持有人包括 PERCEPTIVE ADVISORS LLC、BVF INC/IL、Samsara BioCapital, LLC,按 13F 申报市值在本页 277 家持有人中排名居前。
STRO 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 60 | 6.49M | $104.46M | +16.8% |
| Q2 2026 | 106 | 16.71M | $552.84M | +15.7% |
| Q1 2026 | 79 | 14.14M | $352.18M | +69.5% |
| Q4 2025 | 64 | 5.70M | $65.94M | -89.5% |
| Q3 2025 | 85 | 54.85M | $47.63M | -4.3% |
| Q2 2025 | 100 | 58.23M | $41.57M | +6.0% |
| Q1 2025 | 114 | 60.21M | $39.15M | +6.4% |
| Q4 2024 | 122 | 59.25M | $108.96M | -6.9% |
表内 8 个季度中,机构持股合计减少 89%(Q4 2024 → Q3 2026);单季变动最大的是 Q4 2025(-89.5%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 1.18M | $18.98M | 0.00% | 增持 | |
| 1.15M | $18.57M | 0.86% | 减持 | |
| 676.93K | $10.91M | 0.00% | 减持 | |
| 379.29K | $6.11M | 0.01% | 增持 | |
| 365.85K | $5.90M | 0.00% | 减持 | |
| 324.48K | $5.23M | 0.00% | 增持 | |
| 317.96K | $5.12M | 0.01% | 增持 | |
| 282.76K | $4.56M | 0.00% | 增持 | |
| 272.35K | $4.39M | 0.54% | 持有 | |
| 225.84K | $3.64M | 0.00% | 增持 | |
| 171.25K | $2.76M | 0.00% | 增持 | |
| 115.06K | $1.85M | 0.00% | 减持 | |
| 100.04K | $1.61M | 0.00% | 减持 | |
| 90.54K | $1.46M | 0.03% | 增持 | |
| 87.25K | $1.41M | 0.00% | 增持 | |
| 68.51K | $1.10M | 0.00% | 减持 | |
| 68.30K | $1.10M | 0.01% | 增持 | |
| 64.89K | $1.05M | 0.00% | 增持 | |
| 62.31K | $1.00M | 0.00% | 增持 | |
| 55.24K | $889.88K | 0.00% | 增持 | |
| 51.10K | $823.19K | 0.00% | 增持 | |
| 41.37K | $666.46K | 0.00% | 持有 | |
| 35.30K | $568.60K | 0.00% | 持有 | |
| 34.87K | $561.79K | 0.00% | 减持 | |
| 28.19K | $454.19K | 0.00% | 减持 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 1.30M | $43.32M | 0.69% | 增持 | |
| 1.25M | $41.56M | 1.06% | 持有 | |
| 1.17M | $38.93M | 1.87% | 增持 | |
| 1.12M | $37.27M | 0.00% | 增持 | |
| 1.06M | $35.29M | 2.90% | 持有 | |
| 872.56K | $28.97M | 1.60% | 持有 | |
| 743.94K | $24.70M | 0.50% | 减持 | |
| 711.16K | $23.61M | 0.08% | 增持 | |
| 694.22K | $23.05M | 0.00% | 减持 | |
| 585.26K | $19.43M | 0.26% | 减持 | |
| 512.16K | $17.00M | 10.88% | 持有 | |
| 458.03K | $15.21M | 0.05% | 持有 | |
| 404.01K | $13.41M | 0.74% | 减持 | |
| 389.69K | $12.94M | 0.00% | 新进 | |
| 389.69K | $12.94M | 0.00% | 增持 | |
| 365.97K | $12.15M | 0.01% | 增持 | |
| 365.97K | $12.15M | 0.02% | 增持 | |
| 272.35K | $9.04M | 1.72% | 持有 | |
| 270.25K | $8.97M | 6.25% | 持有 | |
| 244.67K | $8.12M | 0.00% | 新进 | |
| 237.83K | $7.90M | 0.03% | 减持 | |
| 226.57K | $7.52M | 5.52% | 持有 | |
| 208.51K | $6.92M | 0.00% | 减持 | |
| 201.69K | $6.70M | 0.01% | 增持 | |
| 197.56K | $6.56M | 0.00% | 新进 |
Q1 2026 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 1.25M | $31.18M | 0.99% | 新进 | |
| 1.07M | $26.64M | 1.43% | 增持 | |
| 1.06M | $26.48M | 2.57% | 增持 | |
| 872.56K | $21.74M | 1.40% | 增持 | |
| 801.14K | $19.96M | 0.41% | 新进 | |
| 720.44K | $17.95M | 0.00% | 新进 | |
| 715.31K | $17.82M | 0.29% | 新进 | |
| 715.31K | $17.82M | 0.37% | 新进 | |
| 715.31K | $17.82M | 0.19% | 新进 | |
| 692.11K | $17.24M | 0.07% | 增持 | |
| 524.44K | $13.06M | 0.90% | 增持 | |
| 512.16K | $12.76M | 7.99% | 增持 | |
| 465.79K | $11.60M | 0.04% | 增持 | |
| 457.44K | $11.39M | 0.04% | 新进 | |
| 392.87K | $9.79M | 0.00% | 增持 | |
| 272.35K | $6.78M | 1.94% | 持有 | |
| 269.43K | $6.71M | 4.79% | 增持 | |
| 232.68K | $5.80M | 0.00% | 增持 | |
| 226.57K | $5.64M | 4.21% | 新进 | |
| 222.63K | $5.55M | 0.01% | 增持 | |
| 210.38K | $5.24M | 0.00% | 减持 | |
| 210.38K | $5.24M | 0.01% | 减持 | |
| 200.00K | $4.98M | 0.01% | 持有 | |
| 190.67K | $4.75M | 0.64% | 持有 | |
| 171.39K | $4.27M | 0.00% | 增持 |
Q4 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 748.38K | $8.66M | 0.53% | 减持 | |
| 479.59K | $5.55M | 0.37% | 减持 | |
| 418.20K | $4.84M | 0.00% | 减持 | |
| 418.20K | $4.84M | 0.01% | 减持 | |
| 375.79K | $4.35M | 0.00% | 减持 | |
| 312.00K | $3.61M | 2.13% | 减持 | |
| 272.35K | $3.15M | 1.14% | 减持 | |
| 243.00K | $2.81M | 0.10% | 减持 | |
| 230.05K | $2.66M | 0.01% | 新进 | |
| 204.50K | $2.37M | 0.24% | 减持 | |
| 200.00K | $2.31M | 0.00% | 减持 | |
| 193.57K | $2.24M | 0.11% | 减持 | |
| 190.67K | $2.21M | 0.29% | 新进 | |
| 179.09K | $2.07M | 0.01% | 新进 | |
| 139.62K | $1.62M | 0.08% | 减持 | |
| 122.86K | $1.42M | 0.00% | 减持 | |
| 117.44K | $1.36M | 0.00% | 减持 | |
| 89.07K | $1.03M | 0.09% | 减持 | |
| 85.61K | $990.57K | 0.00% | 减持 | |
| 83.98K | $971.99K | 0.00% | 减持 | |
| 75.59K | $874.62K | 0.29% | 新进 | |
| 67.45K | $780.41K | 0.53% | 新进 | |
| 67.08K | $776.08K | 0.06% | 新进 | |
| 46.49K | $537.91K | 0.00% | 减持 | |
| 35.30K | $408.48K | 0.00% | 减持 |
Q3 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 6.49M | $5.63M | 0.15% | 持有 | |
| 5.09M | $4.42M | 0.33% | 持有 | |
| 4.52M | $3.93M | 0.01% | 减持 | |
| 4.52M | $3.93M | 0.00% | 减持 | |
| 3.68M | $3.20M | 0.00% | 减持 | |
| 3.12M | $2.71M | 2.54% | 增持 | |
| 2.83M | $2.46M | 0.10% | 增持 | |
| 2.72M | $2.37M | 1.04% | 持有 | |
| 2.60M | $2.26M | 0.10% | 持有 | |
| 2.29M | $1.99M | 0.15% | 持有 | |
| 2.20M | $1.91M | 0.25% | 持有 | |
| 2.00M | $1.74M | 0.00% | 持有 | |
| 1.85M | $1.60M | 0.00% | 增持 | |
| 1.69M | $1.47M | 0.00% | 减持 | |
| 1.42M | $1.24M | 0.00% | 增持 | |
| 820.95K | $713.19K | 0.00% | 持有 | |
| 752.72K | $653.66K | 0.06% | 持有 | |
| 445.75K | $387.09K | 0.00% | 新进 | |
| 437.08K | $379.56K | 0.10% | 持有 | |
| 396.79K | $344.57K | 0.00% | 增持 | |
| 354.45K | $307.80K | 0.00% | 减持 | |
| 354.45K | $307.80K | 0.00% | 减持 | |
| 352.95K | $306.50K | 0.00% | 持有 | |
| 342.65K | $297.56K | 0.00% | 持有 | |
| 312.05K | $270.99K | 0.05% | 增持 |
Q2 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 6.49M | $4.63M | 0.14% | 减持 | |
| 5.09M | $3.63M | 0.39% | 减持 | |
| 4.73M | $3.38M | 0.01% | 增持 | |
| 4.73M | $3.38M | 0.00% | 增持 | |
| 4.12M | $2.94M | 0.00% | 减持 | |
| 3.06M | $2.18M | 2.16% | 增持 | |
| 2.72M | $1.94M | 0.90% | 持有 | |
| 2.60M | $1.86M | 0.10% | 持有 | |
| 2.56M | $1.83M | 0.09% | 增持 | |
| 2.29M | $1.64M | 0.15% | 持有 | |
| 2.20M | $1.57M | 0.32% | 持有 | |
| 2.11M | $1.50M | 0.00% | 减持 | |
| 2.00M | $1.43M | 0.00% | 持有 | |
| 1.62M | $1.16M | 0.00% | 增持 | |
| 1.01M | $722.98K | 0.00% | 减持 | |
| 1.01M | $722.98K | 0.00% | 减持 | |
| 913.20K | $651.93K | 0.00% | 增持 | |
| 816.91K | $583.41K | 0.00% | 减持 | |
| 752.72K | $537.37K | 0.08% | 持有 | |
| 688.85K | $491.77K | 0.00% | 新进 | |
| 628.47K | $448.83K | 0.00% | 减持 | |
| 500.00K | $356.95K | 0.02% | 新进 | |
| 437.08K | $312.03K | 0.09% | 持有 | |
| 405.75K | $289.66K | 0.00% | 减持 | |
| 370.75K | $264.68K | 0.00% | 增持 |
新建仓(Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 389.69K 股 · $12.94M
- AMERIPRISE FINANCIAL INC 244.67K 股 · $8.12M
- VANGUARD PORTFOLIO MANAGEMENT LLC 197.56K 股 · $6.56M
- Nuveen, LLC 168.00K 股 · $5.58M
- JPMorgan Chase & Co 159.63K 股 · $5.32M
- Seven Fleet Capital Management LP 159.12K 股 · $3.79M
- Qube Research & Technologies Ltd 106.61K 股 · $3.54M
- MACKENZIE FINANCIAL CORP 94.77K 股 · $3.15M
- Y-Intercept (Hong Kong) Ltd 55.88K 股 · $1.86M
- Squarepoint Ops LLC 55.54K 股 · $1.84M
- Sixth Street Partners Management Company, L.P. 49.30K 股 · $1.64M
- BNY Mellon 41.37K 股 · $1.37M
完全清仓(较上季)
- RA CAPITAL MANAGEMENT, L.P. 卖出 715.31K 股 · $17.82M
- ADAGE CAPITAL PARTNERS GP, L.L.C. 卖出 200.00K 股 · $4.98M
- Opaleye Management Inc. 卖出 190.67K 股 · $4.75M
- Eversept Partners, LP 卖出 73.16K 股 · $1.82M
- Burkehill Global Management, LP 卖出 71.53K 股 · $1.78M
- STATE STREET CORP 卖出 52.12K 股 · $1.30M
- JANE STREET GROUP, LLC 卖出 27.76K 股 · $691.50K
- STEMPOINT CAPITAL LP 卖出 23.30K 股 · $580.28K
- Brevan Howard Capital Management LP 卖出 18.79K 股 · $468.08K
- AJU IB Investment Co., Ltd. 卖出 17.50K 股 · $435.93K
- Hudson Bay Capital Management LP 卖出 14.77K 股 · $367.87K
- Jump Financial, LLC 卖出 12.38K 股 · $308.51K
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | 1.18M | 1.12M | 232.68K | 117.44K | 1.69M | 2.11M | 6.20M | 7.59M | 7.02M | — | — | — | — | — | — | — | — | — | — | — |
| Affinity Asset Advisors, LLC | 1.15M | 1.17M | 1.07M | 748.38K | 752.72K | 752.72K | 752.72K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 676.93K | 694.22K | 720.44K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Qube Research & Technologies Ltd | 379.29K | 106.61K | — | — | 65.23K | 115.40K | — | — | 68.90K | 70.61K | — | — | 4.95K | — | — | — | — | — | — | — |
| Geode Capital Management | 365.85K | 389.69K | 171.39K | 83.98K | 820.95K | 816.91K | 1.89M | 1.85M | 1.86M | 1.72M | 1.29M | 1.26M | 1.20M | 1.16M | 1.06M | 1.02M | 850.75K | 814.79K | 788.80K | 743.68K |
| STATE STREET CORP | 324.48K | — | 52.12K | 34.27K | 342.65K | 342.65K | 1.68M | 1.70M | 1.65M | 1.57M | 1.20M | 1.16M | 1.11M | — | — | — | — | — | — | — |
| Marshall Wace | 317.96K | 175.25K | 222.63K | 85.61K | 118.44K | 234.43K | — | — | 30.66K | — | — | — | — | — | 217.91K | 559.91K | 523.62K | 574.24K | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 282.76K | 197.56K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Merck & Co., Inc. | 272.35K | 272.35K | 272.35K | 272.35K | 2.72M | 2.72M | 2.72M | 2.72M | — | — | — | — | — | — | — | — | — | — | — | — |
| JPMorgan Chase & Co | 225.84K | 159.63K | — | 741 | 76.16K | 173.48K | 301.41K | 64.05K | 58.94K | 58.24K | 48.74K | 66.14K | 76.82K | 74.71K | 30.37K | 187.78K | 155.58K | 156.43K | 170.77K | 56.16K |
| Fidelity Management & Research (FMR) | 171.25K | 1.34K | 1.05K | 1.11K | 11.86K | 11.64K | 61.55K | 277.89K | 189.04K | 151.34K | 112.32K | 85.59K | 80.26K | 79.51K | 83.57K | 624.33K | 746.46K | 664.41K | 737.68K | 737.30K |
| UBS Group AG | 115.06K | 208.51K | 392.87K | 7.87K | 1.85M | 1.62M | 75.57K | 183.66K | 165.86K | 31.35K | 64.64K | 59.59K | 35.97K | 30.06K | 82.70K | 72.66K | 1.07K | 3.72K | 110.33K | — |
| VANGUARD FIDUCIARY TRUST CO | 100.04K | 104.23K | 94.84K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Y-Intercept (Hong Kong) Ltd | 90.54K | 55.88K | — | — | — | 66.59K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Renaissance Technologies | 87.25K | 86.32K | 97.82K | 122.86K | 1.42M | 913.20K | 869.00K | 1.02M | 828.10K | 719.50K | 485.80K | 655.80K | 302.90K | 269.50K | 129.40K | 29.90K | 215.90K | 147.70K | — | 48.70K |
| MACKENZIE FINANCIAL CORP | 68.51K | 94.77K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| SIMPLEX TRADING, LLC | 68.30K | 100 | 62 | 700 | 3.00K | 36.20K | 3.20K | — | 400 | — | — | — | — | — | — | — | — | — | — | — |
| Invesco Ltd | 64.89K | 57.30K | 17.16K | 16.97K | 134.92K | 103.32K | 92.14K | 38.75K | 25.13K | 26.26K | 26.20K | 30.62K | 21.39K | 21.78K | 19.44K | 62.74K | 59.30K | 61.32K | 54.13K | 166.22K |
| BNP PARIBAS FINANCIAL MARKETS | 62.31K | 27.38K | 111 | 111 | 1.74K | 2.40K | 155.24K | 150.76K | 82.52K | 6.37K | 98.23K | 16.37K | 33.10K | — | — | — | — | — | — | — |
| Morgan Stanley | 55.24K | 12.36K | 10.53K | 15.92K | 241.88K | 258.60K | 195.86K | 1.52M | 274.08K | 287.81K | 549.37K | 223.92K | 153.25K | 189.60K | 144.42K | 227.93K | 331.57K | 332.11K | 339.19K | 63.50K |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold STRO?
As of 2026-Q2, 106 institutional funds reported holding STRO (SUTRO BIOPHARMA INC) in SEC 13F filings, with a combined reported value of $552.84M.
How many shares of STRO do institutions own?
13F filers reported 16.71M shares of STRO, worth $552.84M in aggregate at the end of 2026-Q2.
Is institutional ownership of STRO rising or falling?
Share counts moved +15.7% versus the prior quarter — accumulation.
Who are the top institutional holders of STRO?
The largest 13F holders are PERCEPTIVE ADVISORS LLC, BVF INC/IL, Samsara BioCapital, LLC, Kynam Capital Management, LP, ORBIMED ADVISORS LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of SUTRO BIOPHARMA INC?
The major shareholders of SUTRO BIOPHARMA INC (STRO) by reported 13F value are PERCEPTIVE ADVISORS LLC, BVF INC/IL, Samsara BioCapital, LLC, Kynam Capital Management, LP, ORBIMED ADVISORS LLC, among 277 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.